首页>
外国专利>
PHARMACEUTICAL COMBINATION COMPRISING NUCLEOTIDE AND NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (SUCH AS TENOFOVIR AND LAMIVUDINE) IN DIFFERENT PARTS OF THE DOSAGE UNIT
PHARMACEUTICAL COMBINATION COMPRISING NUCLEOTIDE AND NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (SUCH AS TENOFOVIR AND LAMIVUDINE) IN DIFFERENT PARTS OF THE DOSAGE UNIT
展开▼
机译:剂量单位不同部分中包含核苷酸和核苷酸逆转录酶抑制剂(如替诺福韦和拉米夫定)的药物组合
展开▼
页面导航
摘要
著录项
相似文献
摘要
A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior art combination therapies. The invention also provides a pharmaceutical product containing the formulation.
展开▼